{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:56:20Z","timestamp":1790830580208,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05964-9","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:09:00Z","timestamp":1790827740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing FDA approved drugs targeting IL-6 associated signalling for the management of rheumatoid arthritis: an in silico and experimental approach"],"prefix":"10.1007","author":[{"given":"Dhawal","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anugya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvnesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"5964_CR1","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.biopha.2018.07.143","volume":"106","author":"SA Adefegha","year":"2018","unstructured":"Adefegha SA, Okeke BM, Oboh G et al (2018) Modulatory effect of eugenol on arginase, nucleotidase, and adenosine deaminase activities of platelets in a carrageenan-induced arthritis rat model: a possible anti-arthritic mechanism of eugenol. Biomed Pharmacother 106:1616\u20131623. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.143","journal-title":"Biomed Pharmacother"},{"key":"5964_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2025.2472402","volume":"0","author":"O Afzal","year":"2025","unstructured":"Afzal O, Alamri MA, Altharawi A et al (2025) Rational design, docking, simulation, synthesis, and in vitro studies of small benzothiazole molecules as selective BACE1 inhibitors. J Biomol Struct Dyn 0:1\u201312. https:\/\/doi.org\/10.1080\/07391102.2025.2472402","journal-title":"J Biomol Struct Dyn"},{"key":"5964_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10822-025-00700-6","volume":"39","author":"V Agarwal","year":"2025","unstructured":"Agarwal V, Raorane CJ, Gupta A et al (2025a) Structure-based identification and experimental evaluation of Oroxin A as a FYN kinase inhibitor. J Comput Aided Mol des 39:120. https:\/\/doi.org\/10.1007\/s10822-025-00700-6","journal-title":"J Comput Aided Mol des"},{"key":"5964_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-025-00742-w","volume":"40","author":"V Agarwal","year":"2025","unstructured":"Agarwal V, Rathore V, Chaudhary A et al (2025b) In silico discovery and experimental validation of natural derivatives as inhibitor of phosphoinositide kinase, PIKfyve. J Comput Aided Mol des 40:30. https:\/\/doi.org\/10.1007\/s10822-025-00742-w","journal-title":"J Comput Aided Mol des"},{"key":"5964_CR5","doi-asserted-by":"publisher","unstructured":"Agarwal V, Haldhar R, Hirad AH et al (2024a) Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches. J Biomol Struct Dyn 1\u201313. https:\/\/doi.org\/10.1080\/07391102.2024.2308072","DOI":"10.1080\/07391102.2024.2308072"},{"key":"5964_CR6","doi-asserted-by":"publisher","unstructured":"Agarwal V, Rehman M, Chaudhary R et al (2024b) Exploring the potential of natural-like compounds as TNF\u03b1 inhibitors: an in-silico approach. Biointerface Res Appl Chem 14. https:\/\/doi.org\/10.33263\/BRIAC142.047","DOI":"10.33263\/BRIAC142.047"},{"key":"5964_CR7","doi-asserted-by":"publisher","unstructured":"Ahmadi M, Yoosefian M (2026) Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer. Sci Rep 16:17272. https:\/\/doi.org\/10.1038\/s41598-026-42656-z","DOI":"10.1038\/s41598-026-42656-z"},{"key":"5964_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CBI20110150","volume":"36","author":"Y Aida","year":"2012","unstructured":"Aida Y, Honda K, Tanigawa S et al (2012) IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes. Cell Biol Int 36:367\u2013376. https:\/\/doi.org\/10.1042\/CBI20110150","journal-title":"Cell Biol Int"},{"key":"5964_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111114","volume":"398","author":"F Alenazi","year":"2024","unstructured":"Alenazi F, Moursi S, Mahmoud MR et al (2024) Withaferin A alleviates inflammation in animal models of arthritis by inhibiting the NF-\u03baB pathway and cytokine release. Chem Biol Interact 398:111114. https:\/\/doi.org\/10.1016\/j.cbi.2024.111114","journal-title":"Chem Biol Interact"},{"key":"5964_CR10","doi-asserted-by":"publisher","unstructured":"Alturki NA, Mashraqi MM, Alzamami A et al (2022) In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27144391","DOI":"10.3390\/molecules27144391"},{"key":"5964_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","volume":"25","author":"C Arnaud","year":"2005","unstructured":"Arnaud C, Burger F, Steffens S et al (2005) Statins reduce interleukin-6\u2013induced C-reactive protein in human hepatocytes. Arterioscler Thromb Vasc Biol 25:1231\u20131236. https:\/\/doi.org\/10.1161\/01.ATV.0000163840.63685.0c","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5964_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jbspin.2010.07.007","volume":"77","author":"E Assier","year":"2010","unstructured":"Assier E, Boissier M-C, Dayer J-M (2010) Interleukin-6: from identification of the cytokine to development of targeted treatments. Jt Bone Spine 77:532\u2013536. https:\/\/doi.org\/10.1016\/j.jbspin.2010.07.007","journal-title":"Jt Bone Spine"},{"key":"5964_CR13","unstructured":"Awuchi CG, Echeta KC (2019) Current developments in sugar alcohols: chemistry, nutrition, and health concerns of sorbitol, xylitol, glycerol, arabitol, inositol, maltitol, and lactitol. Int J Adv Acad Res 5(11):1\u201333"},{"key":"5964_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cyto.2012.01.006","volume":"58","author":"S Banzet","year":"2012","unstructured":"Banzet S, Sanchez H, Chapot R et al (2012) Interleukin-6 contributes to hepcidin mRNA increase in response to exercise. Cytokine 58:158\u2013161. https:\/\/doi.org\/10.1016\/j.cyto.2012.01.006","journal-title":"Cytokine"},{"key":"5964_CR15","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1038\/onc.2015.466","volume":"35","author":"R Bharti","year":"2016","unstructured":"Bharti R, Dey G, Ojha PK et al (2016) Diacerein-mediated inhibition of IL-6\/IL-6R signaling induces apoptotic effects on breast cancer. Oncogene 35:3965\u20133975. https:\/\/doi.org\/10.1038\/onc.2015.466","journal-title":"Oncogene"},{"key":"5964_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/art.41299","volume":"72","author":"A Boyapati","year":"2020","unstructured":"Boyapati A, Schwartzman S, Msihid J et al (2020) Association of high serum interleukin-6 levels with severe progression of rheumatoid arthritis and increased treatment response differentiating sarilumab from adalimumab or methotrexate in a post hoc analysis. Arthritis Rheumatol 72:1456\u20131466. https:\/\/doi.org\/10.1002\/art.41299","journal-title":"Arthritis Rheumatol"},{"key":"5964_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejcb.2010.10.007","volume":"90","author":"A Chalaris","year":"2011","unstructured":"Chalaris A, Garbers C, Rabe B et al (2011) The soluble interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol 90:484\u2013494. https:\/\/doi.org\/10.1016\/j.ejcb.2010.10.007","journal-title":"Eur J Cell Biol"},{"key":"5964_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111046","volume":"125","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary R, Prasad A, Agarwal V et al (2023) Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol 125:111046. https:\/\/doi.org\/10.1016\/j.intimp.2023.111046","journal-title":"Int Immunopharmacol"},{"key":"5964_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s2175-97902017000317256","volume":"53","author":"Q Chen","year":"2017","unstructured":"Chen Q, Niu X, Li N (2017) Exploring the natural chemiome to target interleukin-6 receptor (IL-6R) cytokines: an atomic scale investigation for novel rheumatoid arthritis drug discovery. Braz J Pharm Sci 53:1\u20137. https:\/\/doi.org\/10.1590\/s2175-97902017000317256","journal-title":"Braz J Pharm Sci"},{"key":"5964_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jot.2021.01.003","volume":"28","author":"J Chen","year":"2021","unstructured":"Chen J, Li J, Chen J et al (2021) Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor. J Orthop Transl 28:100\u2013107. https:\/\/doi.org\/10.1016\/j.jot.2021.01.003","journal-title":"J Orthop Transl"},{"key":"5964_CR21","doi-asserted-by":"publisher","unstructured":"Chhetri KB, Poudel R, Sunar A (2026) In silico evaluation of FDA-approved antivirals and corticosteroids against SARS-CoV-2. Sci Rep 16:14827. https:\/\/doi.org\/10.1038\/s41598-026-44640-z","DOI":"10.1038\/s41598-026-44640-z"},{"key":"5964_CR22","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11030-021-10183-w","volume":"25","author":"R Chikhale","year":"2021","unstructured":"Chikhale R, Sinha SK, Wanjari M et al (2021) Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis. Mol Divers 25:1889\u20131904. https:\/\/doi.org\/10.1007\/s11030-021-10183-w","journal-title":"Mol Divers"},{"key":"5964_CR23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5301\/jsrd.5000265","volume":"2","author":"E Choy","year":"2017","unstructured":"Choy E, Rose-John S (2017) Interleukin-6 as a multifunctional regulator: inflammation, immune response, and fibrosis. J Scleroderma Relat Disord 2:S1\u2013S5. https:\/\/doi.org\/10.5301\/jsrd.5000265","journal-title":"J Scleroderma Relat Disord"},{"key":"5964_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/eji.70136","volume":"56","author":"H Costello","year":"2026","unstructured":"Costello H, Woodcock A, Canavan M (2026) Restoring immunological tolerance via dendritic cells in rheumatoid arthritis. Eur J Immunol 56:e70136. https:\/\/doi.org\/10.1002\/eji.70136","journal-title":"Eur J Immunol"},{"key":"5964_CR25","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"5964_CR26","doi-asserted-by":"publisher","unstructured":"Ding Q, Hu W, Wang R et al (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther 8. https:\/\/doi.org\/10.1038\/s41392-023-01331-9","DOI":"10.1038\/s41392-023-01331-9"},{"key":"5964_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41411","volume":"7","author":"W Feng","year":"2017","unstructured":"Feng W, Liu H, Luo T et al (2017) Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways. Sci Rep 7:1\u201311. https:\/\/doi.org\/10.1038\/srep41411","journal-title":"Sci Rep"},{"key":"5964_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10819-7","author":"D Gopal","year":"2024","unstructured":"Gopal D, Muthuraj R, Balaya RDA et al (2024) Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-024-10819-7","journal-title":"Mol Divers"},{"key":"5964_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D et al (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. https:\/\/doi.org\/10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"key":"5964_CR30","first-page":"356","volume":"14","author":"A Gupta","year":"2024","unstructured":"Gupta A, Gupta N, Rajput DS (2024a) In silico identification of promising IL-6 inhibitors among natural derivatives: a docking, MM-GBSA and ADMET study. JCHR 14:356\u2013359","journal-title":"JCHR"},{"key":"5964_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4062\/biomolther.2023.156","volume":"32","author":"A Gupta","year":"2024","unstructured":"Gupta A, Haldhar R, Agarwal V et al (2024b) Exploring the potential of natural products as FoxO1 inhibitors: an in silico approach. Biomol Ther (Seoul) 32:390\u2013398. https:\/\/doi.org\/10.4062\/biomolther.2023.156","journal-title":"Biomol Ther (Seoul)"},{"key":"5964_CR32","doi-asserted-by":"publisher","unstructured":"Harbour SN, DiToro DF, Witte SJ et al (2020) T(H)17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol 5. https:\/\/doi.org\/10.1126\/sciimmunol.aaw2262","DOI":"10.1126\/sciimmunol.aaw2262"},{"key":"5964_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1124\/jpet.102.036137","volume":"303","author":"M Hayashi","year":"2002","unstructured":"Hayashi M, Rho M-C, Fukami A et al (2002) Biological activity of a novel nonpeptide antagonist to the interleukin-6 receptor 20S,21-epoxy-resibufogenin-3-formate. J Pharmacol Exp Ther 303:104\u2013109. https:\/\/doi.org\/10.1124\/jpet.102.036137","journal-title":"J Pharmacol Exp Ther"},{"key":"5964_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jchromb.2010.12.033","volume":"879","author":"K Heinig","year":"2011","unstructured":"Heinig K, Wirz T, Gajate-perez A, Belli S (2011) Determination of Ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography \u2013 tandem mass spectrometry. J Chromatogr B 879:436\u2013442. https:\/\/doi.org\/10.1016\/j.jchromb.2010.12.033","journal-title":"J Chromatogr B"},{"key":"5964_CR35","doi-asserted-by":"publisher","first-page":"15460","DOI":"10.18632\/oncotarget.7102","volume":"7","author":"T-H Heo","year":"2016","unstructured":"Heo T-H, Wahler J, Suh N (2016) Potential therapeutic implications of IL-6\/IL-6R\/gp130-targeting agents in breast cancer. Oncotarget 7:15460\u201315473. https:\/\/doi.org\/10.18632\/oncotarget.7102","journal-title":"Oncotarget"},{"key":"5964_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.102031","volume":"39","author":"Y Hou","year":"2025","unstructured":"Hou Y, Peng Y, Jin J, Li Z (2025) Promise of rheumatoid arthritis therapy: from clinical deep remission to drug-free remission. Best Pract Res Clin Rheumatol 39:102031. https:\/\/doi.org\/10.1016\/j.berh.2024.102031","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5964_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X (2022) The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol 12:1023177. https:\/\/doi.org\/10.3389\/fonc.2022.1023177","journal-title":"Front Oncol"},{"key":"5964_CR38","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/infdis\/jir060","volume":"203","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Martin JN, Sinclair E et al (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD41 T cell recovery on antiretroviral therapy. J Infect Dis 203:1474\u20131483. https:\/\/doi.org\/10.1093\/infdis\/jir060","journal-title":"J Infect Dis"},{"key":"5964_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu430","author":"P Isom\u00e4ki","year":"2014","unstructured":"Isom\u00e4ki P, Junttila I, Vidqvist K-L et al (2014) The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keu430","journal-title":"Rheumatology (Oxford)"},{"key":"5964_CR40","doi-asserted-by":"publisher","unstructured":"Jahid M, Khan KU, Rehan-Ul-Haq, Ahmed RS (2023) Overview of Rheumatoid Arthritis and Scientific Understanding of the Disease. Mediterr J Rheumatol 34:284\u2013291. https:\/\/doi.org\/10.31138\/mjr.20230801.oo","DOI":"10.31138\/mjr.20230801.oo"},{"key":"5964_CR41","doi-asserted-by":"publisher","unstructured":"Jang S, Kwon E-J, Lee JJ (2022) Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23020905","DOI":"10.3390\/ijms23020905"},{"key":"5964_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4137\/BBI.S38317","volume":"10","author":"A John","year":"2016","unstructured":"John A, Umashankar V, Samdani A et al (2016) In silico structure prediction of human fatty acid synthase-dehydratase: a plausible model for understanding active site interactions. Bioinform Biol Insights 10:143\u2013154. https:\/\/doi.org\/10.4137\/BBI.S38317","journal-title":"Bioinform Biol Insights"},{"key":"5964_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","volume":"55","author":"BE Jones","year":"2018","unstructured":"Jones BE, Maerz MD, Buckner JH (2018) IL-6: a cytokine at the crossroads of autoimmunity. Curr Opin Immunol 55:9\u201314. https:\/\/doi.org\/10.1016\/j.coi.2018.09.002","journal-title":"Curr Opin Immunol"},{"key":"5964_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2040622312466908","volume":"4","author":"A Kaneko","year":"2013","unstructured":"Kaneko A (2013) Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy. Ther Adv Chronic Dis 4:15\u201321. https:\/\/doi.org\/10.1177\/2040622312466908","journal-title":"Ther Adv Chronic Dis"},{"key":"5964_CR45","doi-asserted-by":"publisher","unstructured":"Kaushik AS, Agarwal V, Rehman M et al (2025) Flavonoids as modulators of sirtuin-6 for management of metabolic syndrome: an in silico approach. Biointerface Res Appl Chem 15:1\u201320. https:\/\/doi.org\/10.33263\/BRIAC154.050","DOI":"10.33263\/BRIAC154.050"},{"key":"5964_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1515\/jcim-2014-0075","volume":"12","author":"MA Khan","year":"2015","unstructured":"Khan MA, Subramaneyaan M, Arora VK et al (2015) Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats. J Complement Integr Med 12:117\u2013125. https:\/\/doi.org\/10.1515\/jcim-2014-0075","journal-title":"J Complement Integr Med"},{"key":"5964_CR47","doi-asserted-by":"publisher","unstructured":"Kitaura H, Marahleh A, Ohori F et al (2020) Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21145169","DOI":"10.3390\/ijms21145169"},{"key":"5964_CR48","doi-asserted-by":"publisher","first-page":"11201","DOI":"10.1080\/07391102.2023.2260892","volume":"42","author":"S Koirala","year":"2024","unstructured":"Koirala S, Roy R, Samanta S, Mahapatra S (2024a) Plant derived active compounds of ayurvedic neurological formulation, Saraswatharishta as a potential dual leucine zipper kinase inhibitor\u202f: an in-silico study Plant derived active compounds of ayurvedic neurological formulation. J Biomol Struct Dyn 42:11201\u201311214. https:\/\/doi.org\/10.1080\/07391102.2023.2260892","journal-title":"J Biomol Struct Dyn"},{"key":"5964_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/1062936X.2024.2363195","volume":"35","author":"S Koirala","year":"2024","unstructured":"Koirala S, Samanta S, Kar P (2024b) Identification of inhibitors for neurodegenerative diseases targeting dual leucine zipper kinase through virtual screening and molecular dynamics simulations. SAR QSAR Environ Res 35:457\u2013482. https:\/\/doi.org\/10.1080\/1062936X.2024.2363195","journal-title":"SAR QSAR Environ Res"},{"key":"5964_CR50","doi-asserted-by":"publisher","first-page":"13247","DOI":"10.1080\/07391102.2023.2274982","volume":"42","author":"S Koirala","year":"2024","unstructured":"Koirala S, Samanta S, Mahapatra S et al (2024c) Molecular level investigation for identifying potential inhibitors against thymidylate kinase of monkeypox through in silico approaches. J Biomol Struct Dyn 42:13247\u201313260. https:\/\/doi.org\/10.1080\/07391102.2023.2274982","journal-title":"J Biomol Struct Dyn"},{"key":"5964_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2023.100422","volume":"3","author":"CS Kumar","year":"2023","unstructured":"Kumar CS, Narasu ML, Singh CR (2023) Pharmacokinetic analysis and structural optimization of inophyllamine-I to forecast as a possible drug candidate. Phytomedicine plus 3:100422. https:\/\/doi.org\/10.1016\/j.phyplu.2023.100422","journal-title":"Phytomedicine plus"},{"key":"5964_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0195-6701(91)90199-I","volume":"19","author":"YJ Lamb","year":"1991","unstructured":"Lamb YJ (1991) Overview of the role of mupirocin. J Hosp Infect 19:27\u201330. https:\/\/doi.org\/10.1016\/0195-6701(91)90199-I","journal-title":"J Hosp Infect"},{"key":"5964_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69429-w","author":"K Li","year":"2024","unstructured":"Li K, Cai J, Jiang Z et al (2024) Unveiling novel insights into human IL\u20116\u2212IL\u20116R interaction sites through 3D computer\u2011guided docking and systematic site mutagenesis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-69429-w","journal-title":"Sci Rep"},{"key":"5964_CR54","doi-asserted-by":"publisher","unstructured":"Liu Q, Wang H, Lv S et al (2024) The combined use of levodopa\/benserazide and pramipexole proves beneficial for managing Parkinson\u2019s Disease. Actas Esp Psiquiatr 52:769\u2013776. https:\/\/doi.org\/10.62641\/aep.v52i6.1711","DOI":"10.62641\/aep.v52i6.1711"},{"key":"5964_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1890594","author":"AA Mathew","year":"2026","unstructured":"Mathew AA, Rithvik A, Rasool M (2026) Targeting the synovial engine: next-generation engineered immune cells to eradicate pathogenic FLS in rheumatoid arthritis, with safety-first, selective designs. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2026.1890594","journal-title":"Front Immunol"},{"key":"5964_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H et al (2012) IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 122:143\u2013159. https:\/\/doi.org\/10.1042\/CS20110340","journal-title":"Clin Sci (Lond)"},{"key":"5964_CR57","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s11224-022-01999-9","volume":"33","author":"AO Mohammed","year":"2022","unstructured":"Mohammed AO, Abo-Idrees MI, Makki AA et al (2022) Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Struct Chem 33:1553\u20131567. https:\/\/doi.org\/10.1007\/s11224-022-01999-9","journal-title":"Struct Chem"},{"key":"5964_CR58","doi-asserted-by":"publisher","unstructured":"Narazaki M, Kishimoto T (2018) The two-faced cytokine IL-6 in host defense and diseases. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19113528","DOI":"10.3390\/ijms19113528"},{"key":"5964_CR59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI20945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271\u20131276. https:\/\/doi.org\/10.1172\/JCI20945","journal-title":"J Clin Invest"},{"key":"5964_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","volume":"146","author":"DN Ngwa","year":"2022","unstructured":"Ngwa DN, Pathak A, Agrawal A (2022) IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms. Mol Immunol 146:50\u201356. https:\/\/doi.org\/10.1016\/j.molimm.2022.04.003","journal-title":"Mol Immunol"},{"key":"5964_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","volume":"29","author":"A Ogata","year":"2019","unstructured":"Ogata A, Kato Y, Higa S, Yoshizaki K (2019) IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol 29:258\u2013267. https:\/\/doi.org\/10.1080\/14397595.2018.1546357","journal-title":"Mod Rheumatol"},{"key":"5964_CR62","doi-asserted-by":"publisher","unstructured":"Ozbek L, Mizrak B, Yilmaz ZY et al (2025) Association between interleukin 6, C-reactive protein, and kidney transplantation outcomes: a systematic review and meta-analysis. Transpl Immunol 93:102308. https:\/\/doi.org\/10.1016\/j.trim.2025.102308","DOI":"10.1016\/j.trim.2025.102308"},{"key":"5964_CR63","doi-asserted-by":"publisher","unstructured":"Panda S, Kumari L, Badwaik HR, Shanmugarajan D (2022) Computational approaches for drug repositioning and repurposing to combat SARS-CoV-2 infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection, pp 247\u201365.\u00a0https:\/\/doi.org\/10.1016\/B978-0-323-91172-6.00008-X","DOI":"10.1016\/B978-0-323-91172-6.00008-X"},{"key":"5964_CR64","doi-asserted-by":"publisher","unstructured":"Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E (2020) Interleukin-6 in Rheumatoid Arthritis. Int J Mol Sci 21(15):5238.\u00a0https:\/\/doi.org\/10.3390\/ijms21155238","DOI":"10.3390\/ijms21155238"},{"key":"5964_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/17425255.2021.1865309","volume":"17","author":"S Pathania","year":"2021","unstructured":"Pathania S, Singh PK (2021) Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? Expert Opin Drug Metab Toxicol 17:351\u2013354. https:\/\/doi.org\/10.1080\/17425255.2021.1865309","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5964_CR66","doi-asserted-by":"publisher","unstructured":"Piekara A, Krzywonos M, Szyma\u0144ska A (2020) Sweetening agents and sweeteners in dietary supplements for children-analysis of the polish market. Nutrients 12. https:\/\/doi.org\/10.3390\/nu12082387","DOI":"10.3390\/nu12082387"},{"key":"5964_CR67","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"5964_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28716-8","author":"D Pirolli","year":"2023","unstructured":"Pirolli D, Righino B, Camponeschi C et al (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein\/ACE2 interface. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-28716-8","journal-title":"Sci Rep"},{"key":"5964_CR69","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.52711\/0974-360X.2023.00435","volume":"16","author":"B Prabowo","year":"2023","unstructured":"Prabowo B, Raras TYM, Lusida MLI et al (2023) Roles of anti-inflammatory active ingredients of Saussurea costus in silico approach as adjuvant therapy in COVID-19 cases. Res J Pharm Technol 16:2649\u20132654","journal-title":"Res J Pharm Technol"},{"key":"5964_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1586\/14787210.2.1.27","volume":"2","author":"RR Razonable","year":"2004","unstructured":"Razonable RR, Paya CV (2004) Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther 2:27\u201341. https:\/\/doi.org\/10.1586\/14787210.2.1.27","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5964_CR71","doi-asserted-by":"publisher","unstructured":"Rosso M, Saxena S, Chitnis T (2020) Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options. Expert Rev Neurother 20. https:\/\/doi.org\/10.1080\/14737175.2020.1757434","DOI":"10.1080\/14737175.2020.1757434"},{"key":"5964_CR72","doi-asserted-by":"crossref","unstructured":"Sahu A, Pradhan D, Raza K, Qazi S, Jain AK, Verma S (2020). In silico library design, screening and MD simulation of COX-2 inhibitors for anticancer activity. In: Proceedings of the 12th International Conference on Bioinformatics and Computational Biology, vol 70, pp 21\u201332. EPiC Series in Computing","DOI":"10.29007\/z2wx"},{"key":"5964_CR73","doi-asserted-by":"publisher","unstructured":"Salaam RA, Afolayan FID, Olaniyi DA, et al (2025) In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma. Sci Afr 27:e02582. https:\/\/doi.org\/10.1016\/j.sciaf.2025.e02582","DOI":"10.1016\/j.sciaf.2025.e02582"},{"key":"5964_CR74","doi-asserted-by":"publisher","unstructured":"Samanta S, Sk MF, Koirala S, Kar P (2023) Exploring molecular interactions of potential inhibitors against the spleen tyrosine kinase implicated in autoimmune disorders via virtual screening and molecular dynamics simulations. https:\/\/doi.org\/10.1080\/1062936X.2023.2266364","DOI":"10.1080\/1062936X.2023.2266364"},{"key":"5964_CR75","doi-asserted-by":"publisher","unstructured":"Saraiva A, Carrascosa C, Raheem D et al (2020) Maltitol: analytical determination methods, applications in the food industry, metabolism and health impacts. Int J Environ Res Public Health 17. https:\/\/doi.org\/10.3390\/ijerph17145227","DOI":"10.3390\/ijerph17145227"},{"key":"5964_CR76","doi-asserted-by":"publisher","unstructured":"Schmidt-Arras D, Rose-John S (2021) Endosomes as signaling platforms for IL-6 family cytokine receptors. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.688314","DOI":"10.3389\/fcell.2021.688314"},{"key":"5964_CR77","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00277-024-06121-z","volume":"104","author":"L Shakeel","year":"2025","unstructured":"Shakeel L, Khaliq N, Shaukat A et al (2025) The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Ann Hematol 104:1139\u20131155. https:\/\/doi.org\/10.1007\/s00277-024-06121-z","journal-title":"Ann Hematol"},{"key":"5964_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1309\/E5R9P5YPHXFE3198","volume":"130","author":"SG Shelat","year":"2008","unstructured":"Shelat SG, Chacosky D, Shibutani S (2008) Differences in erythrocyte sedimentation rates using the westergren method and a centrifugation method. Am J Clin Pathol 130:127\u2013130. https:\/\/doi.org\/10.1309\/E5R9P5YPHXFE3198","journal-title":"Am J Clin Pathol"},{"key":"5964_CR79","doi-asserted-by":"publisher","first-page":"103696","DOI":"10.1016\/j.drudis.2023.103696","volume":"28","author":"C Shi","year":"2023","unstructured":"Shi C, Zhao H, Fang Y et al (2023) Lactose in tablets\u202f: Functionality, critical material attributes, applications, modi fi cations and co-processed excipients. Drug Discov Today 28:103696. https:\/\/doi.org\/10.1016\/j.drudis.2023.103696","journal-title":"Drug Discov Today"},{"key":"5964_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.6026\/97320630015121","volume":"15","author":"P Shukla","year":"2019","unstructured":"Shukla P, Khandelwal R, Sharma D et al (2019) Virtual Screening of IL-6 Inhibitors for Idiopathic Arthritis. Bioinformation 15:121\u2013130. https:\/\/doi.org\/10.6026\/97320630015121","journal-title":"Bioinformation"},{"key":"5964_CR81","doi-asserted-by":"publisher","first-page":"115797","DOI":"10.1016\/j.intimp.2025.115797","volume":"168","author":"A Singh","year":"2026","unstructured":"Singh A, Chaudhary R, Agarwal V et al (2026) Bezafibrate, a Pan PPAR agonist, attenuates experimental rheumatoid arthritis via PPAR dependent modulation of inflammatory pathways with emphasis on PPAR \u03b3 activity. Int Immunopharmacol 168:115797. https:\/\/doi.org\/10.1016\/j.intimp.2025.115797","journal-title":"Int Immunopharmacol"},{"key":"5964_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M19-3369","volume":"172","author":"DH Solomon","year":"2020","unstructured":"Solomon DH, Glynn RJ, Karlson EW et al (2020) Adverse effects of low-dose methotrexate: a randomized trial. Ann Intern Med 172:369\u2013380. https:\/\/doi.org\/10.7326\/M19-3369","journal-title":"Ann Intern Med"},{"key":"5964_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1759720X10378372","volume":"2","author":"S Srirangan","year":"2010","unstructured":"Srirangan S, Choy EH (2010) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2:247\u2013256. https:\/\/doi.org\/10.1177\/1759720X10378372","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5964_CR84","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"5964_CR85","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2326-6066.CIR-14-0022","volume":"2","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Kishimoto T (2014) The biology and medical implications of interleukin-6. Cancer Immunol Res 2:288\u2013294. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0022","journal-title":"Cancer Immunol Res"},{"key":"5964_CR86","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6:a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5964_CR87","doi-asserted-by":"publisher","unstructured":"Vanshika, Gulati P, Thakur R, et al (2026) New frontiers in rheumatoid arthritis therapy: From classic DMARDs to biologics and beyond. Pathol Res Pract 277:156307. https:\/\/doi.org\/10.1016\/j.prp.2025.156307","DOI":"10.1016\/j.prp.2025.156307"},{"key":"5964_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113819","volume":"43","author":"M Wang","year":"2024","unstructured":"Wang M, Chen L, He J et al (2024) Structural insights into IL-6 signaling inhibition by therapeutic antibodies. Cell Rep 43:113819. https:\/\/doi.org\/10.1016\/j.celrep.2024.113819","journal-title":"Cell Rep"},{"key":"5964_CR89","doi-asserted-by":"publisher","unstructured":"Wang X, Shen Y, Zhuang X, Wang N, Zhang Q, Zhu L, Liu Y, Lu X, Qin L, Zhang Q (2021) Jintiange capsule alleviates rheumatoid arthritis and reverses changes of serum metabolic profile in collagen-induced arthritic rats. J Inflamm Res 14:6685\u20136706.\u00a0https:\/\/doi.org\/10.2147\/JIR.S338107","DOI":"10.2147\/JIR.S338107"},{"key":"5964_CR90","doi-asserted-by":"publisher","unstructured":"Wang J, He L, Li W, Lv S (2022) A Role of IL-17 in Rheumatoid arthritis patients complicated with atherosclerosis. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.828933","DOI":"10.3389\/fphar.2022.828933"},{"key":"5964_CR91","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.joca.2021.01.008","volume":"29","author":"R Wiegertjes","year":"2021","unstructured":"Wiegertjes R, Thielen NGM, van Caam APM et al (2021) Increased IL-6 receptor expression and signaling in ageing cartilage can be explained by loss of TGF-\u03b2-mediated IL-6 receptor suppression. Osteoarthritis Cartilage 29:773\u2013782. https:\/\/doi.org\/10.1016\/j.joca.2021.01.008","journal-title":"Osteoarthritis Cartilage"},{"key":"5964_CR92","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1097\/RHU.0000000000001293","volume":"27","author":"RML Yip","year":"2021","unstructured":"Yip RML, Yim CW (2021) Role of interleukin 6 inhibitors in the management of rheumatoid arthritis. J Clin Rheumatol Pract Reports Rheum Musculoskelet Dis 27:e516\u2013e524. https:\/\/doi.org\/10.1097\/RHU.0000000000001293","journal-title":"J Clin Rheumatol Pract Reports Rheum Musculoskelet Dis"},{"key":"5964_CR93","doi-asserted-by":"publisher","first-page":"698313","DOI":"10.1155\/2014\/698313","volume":"2014","author":"Y Yoshida","year":"2014","unstructured":"Yoshida Y, Tanaka T (2014) Interleukin 6 and rheumatoid arthritis. Biomed Res Int 2014:698313. https:\/\/doi.org\/10.1155\/2014\/698313","journal-title":"Biomed Res Int"},{"key":"5964_CR94","doi-asserted-by":"publisher","unstructured":"Zeb S, Khan Z, Ashraf et al (2024) Relationship between serum interleukin-6 levels, systemic immune-inflammation index, and other biomarkers across different rheumatoid arthritis severity levels. Cureus 16:e72334. https:\/\/doi.org\/10.7759\/cureus.72334","DOI":"10.7759\/cureus.72334"},{"key":"5964_CR95","doi-asserted-by":"publisher","unstructured":"Zhang W, Wang R, Guo R, et al (2025) The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1538601","DOI":"10.3389\/fphar.2025.1538601"},{"key":"5964_CR96","first-page":"94","volume":"2","author":"SG Zheng","year":"2013","unstructured":"Zheng SG (2013) Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? Am J Clin Exp Immunol 2:94\u2013106","journal-title":"Am J Clin Exp Immunol"},{"key":"5964_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106869","volume":"201","author":"LS Zondagh","year":"2024","unstructured":"Zondagh LS, Malan SF, Joubert J (2024) Edaravone N-benzyl pyridinium derivatives: BACE-1 inhibition, kinetics and in silico binding pose determination. Eur J Pharm Sci 201:106869. https:\/\/doi.org\/10.1016\/j.ejps.2024.106869","journal-title":"Eur J Pharm Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05964-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05964-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05964-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:09:05Z","timestamp":1790827745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05964-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":97,"alternative-id":["5964"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05964-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimental protocols were approved by the Institutional Animal Ethics Committee (IAEC) of MET Faculty of Pharmacy (Approval No.: MET\/GOI\/FOP\/435) as per the guidelines of CCSEA.","order":4,"name":"Ethics","label":"Animal ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}